SAGE(short, 10 nt tags) Show
SAGE(long, 17 nt tags) Show
MPSS (short, 13 nt tags) Show
EST Show
![]() | ||
![]() | ||
The figures shown in this section represent a standardized analysis of all reported CT-antigens in the same set of mRNA preparations from
normal human tissues and a selection of human cancer cell lines. The analysis was done by RT-PCR using the primer pairs indicated for each gene.
A total of 1.0 �g of RNA was reverse-transcribed into cDNA using the Omniscript RT kit (Qiagen, Valencia, CA) using oligo (dT)18 primers
(Invitrogen, Carlsbad, CA). JumpStart REDTaq� ReadyMix-(Sigma Aldrich, St. Louis,MO) was used for amplification according to the manufacturer's
instructions. Samples were amplified with a precycling hold at 95oC for 3 min, followed by 35 specific cycles of denaturation at 95oC
for 15 seconds,annealing for 30 seconds (10 cycles at 60oC, 10 cycles at 58oC and 15 cycles at 56oC) and extension at 72oC for 30 seconds followed by a final
extension step at 72oC for 7 minutes. The RT-PCR products were run on 1.5% agarose gels and stained by ethidium bromide. |
Tissue | Methodology | PMID |
---|---|---|
Testis | Northern blot | 10980622 |
Bone marrow | Northern blot | 10980622 |
Thymus | Northern blot | 10980622 |
Placenta | Northern blot | 10980622 |
Fetal liver | Northern blot | 10980622 |
Colon | Northern blot | 10980622 |
Small intestine | Northern blot | 10980622 |
Appendix | Northern blot | 10980622 |
Testis | Northern blot | 12618768 |
Thymus | Northern blot | 12618768 |
Placenta | Northern blot | 12618768 |
Fetal liver | Northern blot | 12618768 |
Testis | Northern blot | 12087463 |
Hematologic malignacies Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Myeloma |
Newly diagnosed patient | 238/320 (74%) | Microarray | 21738656 |
Myeloma |
Relapse patient | 236/264 (89%) | Microarray |
Gynecological cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Cervical carcinoma |
3/8 (38%) | RT-PCR | 12087463 |
Lung cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Lung carcinoma |
19/46 (41%) | RT-PCR | 12087463 |
Ovarian cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Ovarian carcinoma |
4/11 (36%) | RT-PCR | 12087463 |
Origin tissue | Cell Line ID | Frequency | Methodology | PMID |
---|---|---|---|---|
Bladder carcinoma | DAB-1 T-24 UMUC-2 |
RT-PCR | 12087463 | |
Breast carcinoma | MCF-7 | RT-PCR | 12087463 | |
Breast carcinoma | T47D | Northern blot | 10980622 | |
Cervical carcinoma | HeLa | RT-PCR | 12087463 | |
Esophageal carcinoma | TE-8 | RT-PCR | 12087463 | |
Head and Neck squamous carcinoma (Oral) | HSC-2 | RT-PCR | 12087463 | |
Hepatocellular carcinoma | HepG2 | Northern blot | 10980622 | |
Leukemia | HL60 | RT-PCR | 12087463 | |
Lung carcinoma | PI10 NCIH226 RERF-LC-MS RERF-LC-OK |
RT-PCR | 12087463 | |
Lymphoma (T Cell Lymphoma) | Jurkat | RT-PCR | 12087463 | |
Melanoma | SKMEL.AKI G361 |
RT-PCR | 12087463 | |
Pancreatic carcinoma | PCI43 | RT-PCR | 12087463 | |
Skin squamous cell carcinoma | A431 | RT-PCR | 12087463 |
2005-2009© CT Antigens Database